Ariad Pharma Rises on FDA Decision
Shares of Ariad Pharmaceuticals saw a modest gain early Monday after the company announced a recent FDA decision.
All Work
Chris Lange
SEC Charges LA-Based Firm With Overbilling Clients
The SEC has charged a Los-Angeles based investment advisory firm and its owner with fraudulently overbilling clients and stealing assets from their trusts to pay for personal expenses.
7 Key Tech and Media Earnings Coming This Week
24/7 Wall St. has put together a preview of Facebook, Alibaba and some of the other top tech and media companies reporting their quarterly results this week.
8 Top Earnings for the Week Ahead
24/7 Wall St. has put together a preview of Pfizer, Starbucks and some of the major companies reporting their quarterly results this week.
Genocea Biosciences Rises on Positive Herpes Trial Results
Genocea Biosciences shares saw a handy gain early Friday following the release of mid-stage results from its genital herpes treatment.
Goodyear Underwhelms in Q3
Goodyear Tire & Rubber reported disappointing third-quarter financial results before the markets opened on Friday.
BlackLine Enters the Market With a Bang
Out of all the initial public offerings that happened this past week, BlackLine was by far the most successful. It priced above the high end of its expected price range.
6 Companies That Destroyed Shareholders Last Week
The broad markets are holding steady near their double bottom set this summer. However, over the course of the past week this has been tested.
Why Analysts Are Taking Mixed Views on Amazon After Earnings
Some analysts saw Amazon's latest results as a potential slow down, while others were expecting a pullback eventually, with all the recent success this company has had.
What Analysts Are Saying About Alphabet After Earnings
After Alphabet reported third-quarter 2016 results on Thursday, a few key analysts had important takeaways from the report, and across the board price targets went up.
Is This the Beginning of the End of Opexa?
Opexa Therapeutics Inc. (NASDAQ: OPXA) shares were in free fall Friday morning after the company reported results from its mid-stage trial for the treatment of secondary progressive multiple sclerosis. The company said that its…
AbbVie Slides on Top-Line Miss
AbbVie reported mixed third-quarter financial results and a dividend hike before the markets opened on Friday.
Amgen Sinks Despite Beating Street Estimates
Though Amgen reported better-than-expected third-quarter results on Thursday, shares sank early Friday.
Why Amazon Disappointed This Quarter
When Amazon.com reported third-quarter financial results on Thursday, it disappointed on the bottom line, but this is nothing longtime Amazon investors haven't dealt with before.
Quantenna Communications Closes in on IPO
Quantenna Communications registered an amended Form S-1 with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO). The company intends to price its 6.7 million shares in the range of…
What to Watch When Amgen Reports Earnings
Biotech giant Amgen is scheduled to release its third-quarter financial results after the markets close on Thursday.
Myovant Sciences Enters the Market in IPO
Myovant Sciences entered the market near the high end of its expected price range for its initial public offering.
ZTO Express Underwhelms in IPO
ZTO Express entered the market below its target in its initial public offering, but still at the high end of its expected pricing range.
ReWalk Robotics Slides on Secondary Offering
ReWalk Robotics shares dropped after it announced the pricing of a secondary offering of more than 3 million units.
ProQR Jumps on Positive Phase 1 Results
Shares of ProQR Therapeutics jumped early on Thursday after the company announced results from its cystic fibrosis study.